GlassScriptPhysician profile
Ramy S Doss
NPI 1629032487
$19,206.26
in general payments reported to CMS, 2019-2025
55 companies · $3,899 in 2025
The $3,899 reported for 2025 was more than what 90% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,446 · 2020: $1,328 · 2021: $4,596 · 2022: $2,533 · 2023: $2,516 · 2024: $1,887 · 2025: $3,899.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,315 · Travel and Lodging: $1,798 · Education: $188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,315.11 |
| Travel and Lodging | $1,798.46 |
| Education | $188.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $2,949.58 | 2025 | |
| Angiodynamics, INC. | $1,681.15 | 2021 | |
| Amgen INC. | $1,660.62 | 2019-2024 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,274.98 | 2019-2024 | Lifevest |
| Pfizer INC. | $1,006.25 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $925.74 | 2019-2025 | |
| Kowa Pharmaceuticals America, INC. | $864.46 | 2019-2023 | Livalo |
| Merck Sharp & Dohme LLC | $805.20 | 2021-2024 | Verquvo |
| Novo Nordisk INC | $677.74 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Amarin Pharma, INC. | $576.35 | 2019-2023 | |
| Impulse Dynamics (USA) INC. | $511.17 | 2022-2023 | Optimizer |
| Medtronic, INC. | $498.40 | 2021-2025 | Advisa Dr Mri Surescan, Micra |
| Esperion Therapeutics, INC. | $442.29 | 2020-2025 | Nexletol |
| E.R. Squibb & Sons, L.L.C. | $436.68 | 2019-2024 | Camzyos, Eliquis |
| Boston Scientific Corporation | $370.12 | 2020-2025 | General - Vascular Intervention, Varithena Administration Pack |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $357.20 | 2019-2024 | Wainua |
| Heartflow, INC. | $328.90 | 2022-2024 | Ffrct |
| Lexicon Pharmaceuticals, INC. | $320.08 | 2023-2024 | Inpefa |
| Janssen Pharmaceuticals, INC | $300.98 | 2019-2021 | |
| Astellas Pharma US INC | $285.80 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $264.16 | 2021-2024 | Jardiance |
| Alnylam Pharmaceuticals INC. | $260.54 | 2019-2025 | Amvuttra |
| Edwards Lifesciences Corporation | $258.53 | 2019-2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Irhythm Technologies, INC. | $217.52 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $194.90 | 2019-2023 | |
| Tactile Systems Technology INC | $186.59 | 2023 | Entre Plus, Flexitouch Plus |
| Actelion Pharmaceuticals US, INC. | $150.74 | 2020-2024 | Uptravi, Opsumit |
| Daiichi Sankyo INC. | $132.72 | 2019-2023 | Injectafer |
| Regeneron Healthcare Solutions, INC. | $124.20 | 2019 | |
| Abbott Laboratories | $117.21 | 2019-2023 | Mitraclip |
| Csl Behring | $95.43 | 2019-2023 | Kcentra |
| Corcept Therapeutics | $70.13 | 2020-2022 | |
| Abiomed | $67.63 | 2022 | |
| Arbor Pharmaceuticals, INC. | $66.70 | 2019-2021 | |
| Zoll Respicardia, INC. | $65.97 | 2023 | Remede System |
| Cardiva Medical, INC. | $63.76 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Baxter Healthcare | $60.60 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Travere Therapeutics, INC. | $46.25 | 2019-2023 | Cholbam |
| Inspire Medical Systems, INC. | $45.96 | 2023-2024 | Inspire |
| Ucb, INC. | $44.77 | 2025 | Nayzilam, Fintepla |
| Takeda Pharmaceuticals U.S.A., INC. | $44.01 | 2025 | Glassia |
| Altathera Pharmaceuticals LLC | $39.45 | 2025 | Sotalol Hydrochloride |
| Itamar Medical INC | $37.08 | 2021 | |
| Endotronix, INC. | $33.83 | 2024 | Cordella Pulomonary Artery Pressure Sensor |
| Kiniksa Pharmaceuticals International, Plc | $31.61 | 2024 | Arcalyst |
| Gilead Sciences, INC. | $31.42 | 2019-2025 | |
| Rhythm Pharmaceuticals, INC. | $28.13 | 2025 | Imcivree |
| Verona Pharma, INC. | $27.10 | 2025 | Ohtuvayre |
| Cvrx, INC. | $24.84 | 2024 | Barostim Neo System |
| Acera Surgical, INC. | $24.79 | 2025 | Restrata Wound Matrix |
| Aegerion Pharmaceuticals, INC. | $20.51 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $19.61 | 2023 | Arcalyst |
| Azurity Pharmaceuticals, INC. | $13.68 | 2024 | Edarbi |
| Amryt Pharma Holdings LTD | $12.15 | 2021 | |
| Vivaquant INC, Dba Rhythm Express | $10.05 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramy Doss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.